The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment.

Pierre Pradat; Marianne Maynard; Maria Buti; Pascale Berthillon; Gaston Picchio; Hans L Tillmann; Johannes Wiegand; Nicolas Voirin; Michael P Manns; Juan-Ignacio Esteban

doi:10.1002/jmv.20104

The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment.

Identifier:nobleid.org/w1/20260515/2AC2A409

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2AC2A409.svg?ark=w1%2F20260515%2F2AC2A409)](https://nobleid.org/work/w1/20260515/2AC2A409)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment.

Identifier:nobleid.org/w1/20260515/2AC2A409

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2AC2A409.svg?ark=w1%2F20260515%2F2AC2A409)](https://nobleid.org/work/w1/20260515/2AC2A409)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work